JD Health International Future Growth
Future criteria checks 3/6
JD Health International is forecast to grow earnings and revenue by 15.5% and 10.6% per annum respectively. EPS is expected to grow by 15.1% per annum. Return on equity is forecast to be 7.9% in 3 years.
Key information
15.5%
Earnings growth rate
15.1%
EPS growth rate
| Consumer Retailing earnings growth | 28.2% |
| Revenue growth rate | 10.6% |
| Future return on equity | 7.9% |
| Analyst coverage | Good |
| Last updated | 18 Dec 2024 |
Recent future growth updates
Recent updates
JD Health International's (HKG:6618) Returns On Capital Not Reflecting Well On The Business
Dec 17
Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects
Nov 04Is Now An Opportune Moment To Examine JD Health International Inc. (HKG:6618)?
Sep 26A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Sep 05Results: JD Health International Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 19The Returns On Capital At JD Health International (HKG:6618) Don't Inspire Confidence
Aug 08Why We're Not Concerned About JD Health International Inc.'s (HKG:6618) Share Price
Jul 21This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate
Jun 14Calculating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
May 21JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Apr 17JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return
Apr 08At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?
Mar 01Revenues Tell The Story For JD Health International Inc. (HKG:6618)
Jan 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 72,533 | 4,078 | 8,486 | 8,016 | 16 |
| 12/31/2025 | 64,982 | 3,656 | 7,069 | 5,709 | 18 |
| 12/31/2024 | 57,795 | 3,152 | 5,228 | 4,322 | 18 |
| 6/30/2024 | 54,764 | 2,618 | 6,436 | 6,467 | N/A |
| 3/31/2024 | 54,147 | 2,380 | 5,490 | 5,536 | N/A |
| 12/31/2023 | 53,530 | 2,142 | 4,544 | 4,605 | N/A |
| 9/30/2023 | 53,576 | 1,930 | 3,135 | 4,311 | N/A |
| 6/30/2023 | 53,621 | 1,718 | 1,726 | 4,017 | N/A |
| 3/31/2023 | 50,179 | 1,049 | 2,679 | 4,961 | N/A |
| 12/31/2022 | 46,736 | 380 | 3,632 | 5,905 | N/A |
| 9/30/2022 | 42,003 | -7 | 3,440 | 4,829 | N/A |
| 6/30/2022 | 37,270 | -395 | 3,249 | 3,753 | N/A |
| 3/31/2022 | 33,976 | -734 | 3,085 | 3,592 | N/A |
| 12/31/2021 | 30,682 | -1,074 | 2,921 | 3,431 | N/A |
| 9/30/2021 | 27,463 | -6,702 | 4,068 | 4,352 | N/A |
| 6/30/2021 | 24,243 | -12,331 | 5,216 | 5,274 | N/A |
| 3/31/2021 | 21,813 | -14,783 | 4,439 | 4,487 | N/A |
| 12/31/2020 | 19,383 | -17,234 | 3,662 | 3,699 | N/A |
| 9/30/2020 | 17,007 | -11,901 | 1,980 | 2,004 | N/A |
| 6/30/2020 | 14,631 | -6,567 | 298 | 309 | N/A |
| 3/31/2020 | 12,737 | -3,769 | 351 | 359 | N/A |
| 12/31/2019 | 10,842 | -972 | 404 | 409 | N/A |
| 12/31/2018 | 8,169 | 215 | 185 | 187 | N/A |
| 12/31/2017 | 5,553 | 179 | N/A | 36 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6618's forecast earnings growth (15.5% per year) is above the savings rate (2.3%).
Earnings vs Market: 6618's earnings (15.5% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).
High Growth Earnings: 6618's earnings are forecast to grow, but not significantly.
Revenue vs Market: 6618's revenue (10.6% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).
High Growth Revenue: 6618's revenue (10.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6618's Return on Equity is forecast to be low in 3 years time (7.9%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 18:45 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
JD Health International Inc. is covered by 32 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yiqun Chen | BOCI Research Ltd. |
| Xiaomeng Zhuang | BofA Global Research |
| Shun Kei Law | CCB International Securities Limited |